Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder

被引:4
作者
Yan, Hongjing [1 ]
Wang, Yining [1 ]
Li, Yanmei [1 ]
Shen, Xiaoling [1 ]
Ma, Lifen [1 ]
Wang, Min [1 ]
Du, Juan [1 ]
Chen, Weifeng [2 ]
Xi, Xutao [3 ]
Li, Bin [4 ]
机构
[1] Handan First Hosp, Dept Neurol, Handan, Peoples R China
[2] Cent Hosp Handan, Dept Neurosurg, Handan, Peoples R China
[3] Handan First Hosp, Dept Orthoped, Handan, Hebei, Peoples R China
[4] University, Hosp Hebei Med 2, Dept Neurol, Shijiazhuang, Peoples R China
关键词
Blood-brain barrier; NMOSD; Platelet to lymphocyte ratio; Biomarkers; Cerebrospinal fluid albumin/serum albumin; MULTIPLE-SCLEROSIS; EXPERIMENTAL-MODELS; DISEASE-ACTIVITY; NEUTROPHIL;
D O I
10.1007/s10072-023-07058-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Neuromyelitis optica spectrum disorder (NMOSD) is a complex neuroinflammatory disease characterized by severe disability. In this study, we investigated the relationship between cerebrospinal fluid (CSF)/serum albumin quotient (Qalb) and platelet to lymphocyte ratio (PLR) in assessing disease severity.Method A retrospective analysis of 72 NMOSD patients and 72 healthy controls was conducted, and patients were divided into two groups based on their Expanded Disability Status Scale (EDSS) scores.Results NMOSD patients had significantly higher levels of serum PLR, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and C-reactive protein (CRP) compared to healthy controls (all P<0.01). Patients in the EDSS & GE;4 group exhibited significantly elevated levels of Qalb, QIgG, QIgA, QIgM, and PLR (P=0.000, P<0.0001, P=0.0019, P=0.0001, respectively). Spearman's correlation test revealed significant positive associations between Qalb, QIgG, QIgA, QIgM, PLR, and EDSS score. Specifically, Qalb (r=0.571; P<0.001), QIgG (r=0.551; P<0.001), QIgA (r=0.519; P<0.001), and QIgM (r=0.541; P<0.001) demonstrated significant positive correlations with EDSS score, while PLR exhibited a moderate positive correlation (r=0.545; P<0.001) with EDSS score and a mild positive association (r=0.387; P<0.001) with Qalb. The increase of Qalb was positively correlated with the increased EDSS score (r=0.528, P=0.001), as well as the increase of QIgG (r=0.509, P=0.001), and the increase of QIgA (r=0.4989, P=0.03). ROC analysis indicated that Qalb, QIgG, QIgA, QIgM, and PLR levels could effectively serve as indicators of NMOSD severity (all P<0.0001). Multivariate analysis confirmed the independent significance of Qalb and PLR in assessing disease severity (P=0.000).Conclusion These findings provide valuable insights into the risk and pathogenesis of NMOSD and highlight the potential of Qalb and PLR as independent markers for disease severity assessment in NMOSD patients.
引用
收藏
页码:709 / 718
页数:10
相关论文
共 32 条
  • [1] Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder
    Hongjing Yan
    Yining Wang
    Yanmei Li
    Xiaoling Shen
    Lifen Ma
    Min Wang
    Juan Du
    Weifeng Chen
    Xutao Xi
    Bin Li
    Neurological Sciences, 2024, 45 : 709 - 718
  • [2] Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients
    You Xiaofan
    Yan Lirong
    Li Xin
    Pang Ying
    Guo Xiaolei
    Ye Jing
    Hu Hongtao
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 254 - 259
  • [3] Acute neuromyelitis optica spectrum disorder patients' clinical analysis of disability-related biomarkers
    Zheng, Xingyue
    Yan, Hongjing
    Yin, Hao
    Shi, Jing
    Liu, Yuanyuan
    Zhao, Haotian
    Li, Yuzhi
    Liu, Huakun
    Zhang, Lei
    Yan, Zhongrui
    Dong, Chunbo
    BMC NEUROLOGY, 2025, 25 (01)
  • [4] Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis
    Liang, Shuolin
    Qin, Qiuhong
    Tang, Yulan
    Liao, Weijing
    Yang, Yi
    He, Jinrong
    Li, Liangsheng
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (02) : 324 - 330
  • [5] Sera from neuromyelitis optica patients disrupt the blood-brain barrier
    Shimizu, Fumitaka
    Sano, Yasuteru
    Takahashi, Toshiyuki
    Haruki, Hiroyo
    Saito, Kazuyuki
    Koga, Michiaki
    Kanda, Takashi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03) : 288 - 297
  • [6] Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro
    Takeshita, Yukio
    Obermeier, Birgit
    Cotleur, Anne C.
    Spampinato, Simona F.
    Shimizu, Fumitaka
    Yamamoto, Erin
    Sano, Yasuteru
    Kryzer, Thomas J.
    Lennon, Vanda A.
    Kanda, Takashi
    Ransohoff, Richard M.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (01):
  • [7] Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability
    Tomizawa, Y.
    Yokoyama, K.
    Saiki, S.
    Takahashi, T.
    Matsuoka, J.
    Hattori, N.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (04) : 1483 - 1491
  • [8] Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration
    Winkler, Anne
    Wrzos, Claudia
    Haberl, Michael
    Weil, Marie-Theres
    Gao, Ming
    Moebius, Wiebke
    Odoardi, Francesca
    Thal, Dietmar R.
    Chang, Mayland
    Opdenakker, Ghislain
    Bennett, Jeffrey L.
    Nessler, Stefan
    Stadelmann, Christine
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (05)
  • [9] Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica
    Saiki, Shinji
    Ueno, Yuji
    Moritani, Toshio
    Sato, Takeshi
    Sekine, Takeshi
    Kawajiri, Sumihiro
    Adachi, Satoshi
    Yokoyama, Kazumasa
    Tomizawa, Yuji
    Motoi, Yumiko
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 284 (1-2) : 217 - 219
  • [10] Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder
    Masuda, Hiroki
    Mori, Masahiro
    Uchida, Tomohiko
    Uzawa, Akiyuki
    Ohtani, Ryohei
    Kuwabara, Satoshi
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 305 : 102 - 107